Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume 23, Issue 4, Pages 812-823
Publisher
Springer Nature
Online
2017-11-21
DOI
10.1038/mp.2017.241
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of a ketamine metabolite on synaptic NMDAR function
- (2017) Kanzo Suzuki et al. NATURE
- Essential Role of Mesolimbic Brain-Derived Neurotrophic Factor in Chronic Social Stress–Induced Depressive Behaviors
- (2016) Ja Wook Koo et al. BIOLOGICAL PSYCHIATRY
- Chronic Ampakine Treatments Stimulate Dendritic Growth and Promote Learning in Middle-Aged Rats
- (2016) Julie C. Lauterborn et al. JOURNAL OF NEUROSCIENCE
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Pluripotent stem cells in disease modelling and drug discovery
- (2016) Yishai Avior et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- BDNF – a key transducer of antidepressant effects
- (2016) Carl Björkholm et al. NEUROPHARMACOLOGY
- Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition
- (2016) Oliver H. Miller et al. NEUROPHARMACOLOGY
- The use of ketamine as an antidepressant: a systematic review and meta-analysis
- (2015) Caoimhe M. Coyle et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- The Transfection of BDNF to Dopamine Neurons Potentiates the Effect of Dopamine D3 Receptor Agonist Recovering the Striatal Innervation, Dendritic Spines and Motor Behavior in an Aged Rat Model of Parkinson’s Disease
- (2015) Luis F. Razgado-Hernandez et al. PLoS One
- Restoring Mood Balance in Depression: Ketamine Reverses Deficit in Dopamine-Dependent Synaptic Plasticity
- (2014) Pauline Belujon et al. BIOLOGICAL PSYCHIATRY
- Enduring Deficits in Brain Reward Function after Chronic Social Defeat in Rats: Susceptibility, Resilience, and Antidepressant Response
- (2014) Andre Der-Avakian et al. BIOLOGICAL PSYCHIATRY
- Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
- (2013) John H. Krystal et al. BIOLOGICAL PSYCHIATRY
- Dopamine D3 receptor as a new pharmacological target for the treatment of depression
- (2013) Gian Marco Leggio et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
- (2013) W. Zhou et al. EUROPEAN PSYCHIATRY
- Electroconvulsive therapy-induced brain plasticity determines therapeutic outcome in mood disorders
- (2013) J. Dukart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
- (2013) Caroline A. Browne et al. Frontiers in Pharmacology
- Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression
- (2012) Xiaochen Zhao et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Glucocorticoids Modulate the mTOR Pathway in the Hippocampus: Differential Effects Depending on Stress History
- (2012) J. Annelies E. Polman et al. ENDOCRINOLOGY
- Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial
- (2012) Kari R Nations et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Dopamine D1, D2, D3 Receptors, Vesicular Monoamine Transporter Type-2 (VMAT2) and Dopamine Transporter (DAT) Densities in Aged Human Brain
- (2012) Jianjun Sun et al. PLoS One
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Pre-synaptic dopamine D3 receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways
- (2011) Ginetta Collo et al. JOURNAL OF NEUROCHEMISTRY
- Escalated or Suppressed Cocaine Reward, Tegmental BDNF, and Accumbal Dopamine Caused by Episodic versus Continuous Social Stress in Rats
- (2011) K. A. Miczek et al. JOURNAL OF NEUROSCIENCE
- Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease
- (2011) Sonja Kriks et al. NATURE
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Towards a glutamate hypothesis of depression
- (2011) Gerard Sanacora et al. NEUROPHARMACOLOGY
- The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
- (2011) Courtney S. Jernigan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Structural and synaptic plasticity in stress-related disorders
- (2011) Daniel J. Christoffel et al. REVIEWS IN THE NEUROSCIENCES
- Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
- (2011) Michael J. Devine et al. Nature Communications
- Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist
- (2010) Graham Searle et al. BIOLOGICAL PSYCHIATRY
- The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity
- (2010) Eero Castrén et al. Developmental Neurobiology
- Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2010) Paolo Barone et al. LANCET NEUROLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats
- (2009) Megan E. Breuer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus
- (2009) Fenghua Chen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation
- (2009) H. Jourdi et al. JOURNAL OF NEUROSCIENCE
- Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
- (2008) Wayne C. Drevets et al. Brain Structure & Function
- Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation
- (2008) Ginetta Collo et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling
- (2008) J M Bessa et al. MOLECULAR PSYCHIATRY
- Role of NMDA Receptors in Dopamine Neurons for Plasticity and Addictive Behaviors
- (2008) Larry S. Zweifel et al. NEURON
- AMPA glutamate receptor subunits 1 and 2 regulate dendrite complexity and spine motility in neurons of the developing neocortex
- (2008) W. Chen et al. NEUROSCIENCE
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started